Drug Target Review2023-09-13T10:00:43
Researchers have developed a novel test capable of detecting a form of cervical cancer that frequently eludes detection through traditional Pap tests.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-11-17T09:31:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2026-06-30T14:00:00
Sponsored by Analytik Jena GmbH + Co. KG
2026-09-18T15:56:00
Contributor Dr Garegin Papoian, Drug Target Review
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2026-11-11T14:00:00
Sponsored by Cell Signaling Technology
2023-07-11T16:13:06
Sponsored by Agilent
Site powered by Webvision Cloud